Research Paper Volume 16, Issue 3 pp 2848—2865
Mechanism of Erianin anti-triple negative breast cancer based on transcriptomics methods and network pharmacology
Figure 6. Molecular docking results of Hub protein and Erianin. (A) Table of molecular docking results of Erianin and hub genes. (B–G) The molecular docking visualization results of Erianin binding to PPARA, ROCK2, PDGFRB, CCND1, MUC1 and CDK1.